1. Randomized trial comparing luteinizing hormone supplementation timing strategies in older women undergoing ovarian stimulation 
Hermann M. Behre, Colin M. Howles, Salvatore Longobardi 
Reproductive BioMedicine Online 
Volume 31, Issue 3, Pages (September 2015)
DOI: /j.rbmo
Copyright © 2015 The Authors Terms and Conditions

2. Figure 1
Patient disposition for those receiving recombinant human follicle-stimulating hormone (rhFSH) plus recombinant human luteinizing hormone (rhLH) (2:1) from stimulation day 1 (group A), or rhFSH from days 1–5, then rhFSH plus rhLH (2:1) from day 6 (group B). Clinical pregnancy was defined as the presence of at least one gestational sac in the uterus with fetal heart activity confirmed by ultrasound on days 35–42 after HCG. GnRH = gonadotrophin-releasing hormone; mITT = modified intention-to-treat; OHSS = ovarian hyperstimulation syndrome.
Reproductive BioMedicine Online  , DOI: ( /j.rbmo )
Copyright © 2015 The Authors Terms and Conditions